Mapping the KRAS Proteoform in Colorectal Cancer - MagLab
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab | 2 Minute Medicine
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study | BMJ Open
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
The mutation distribution of KRAS/NRAS/BRAF in (A) colon cancer, (B)... | Download Scientific Diagram
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer | Semantic Scholar
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Frontiers | Molecular Network of Colorectal Cancer and Current Therapeutic Options
